Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Globus Licenses Renewal - NIH/NEI

Active
7571TE26Q00161Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human ServicesView Agency

NAICS

541519 - Other Computer Related ServicesView NAICS

Place of Performance

Bethesda, MD, 20817, USA

Set-Aside

NONE

Documents

(3)

RFQ+7571TE26Q00161.pdf

PDF

Notice+of+Intent+-+Globus.pdf

PDF

RFQ+7571TE26Q00161+-+BNJ.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services
Contacts2 people available
OfficeWashington, DC, 20201, USA
Organization / Agency
Department Of Health And Human Services
View Agency Profile
Office AddressWashington, DC, 20201, USA
Contacts
Em'Ria Briscoe

Full Description

Show more

The National Eye Institute (NEI) requires the renewal of its existing Globus software subscription and associated support services to maintain uninterrupted, secure, highperformance data transfer and collaboration capabilities across NEI research environments. The renewal will continue the operation of the currently deployed Globus platform, including access to vendor technical support, software updates, security patches, and existing integrations with NIH systems, including the Biowulf High Performance Computing (HPC) environment.

Similar Contracts

Same NAICS industry code

NAICS: 541519
New
Federal
Instrument Manager OEM Laboratory Middleware Software Solution
Solicitation # HT941026QE028
The Defense Health Agency is conducting market research through a sources-sought notice to assess industry capabilities for providing original equipment manufacturer support for the government-owned Instrument Manager laboratory middleware software solution, which is currently deployed at Madigan Army Medical Center in Washington. This effort is focused on securing ongoing maintenance, technical support, software updates, integration services, and training for the system and its associated modules, including core components such as LCT-CS-MAS-01 for maintenance, LCT-IM-CS-01-ESU for emergency security updates, and various test and configuration modules like LCT-IM-B02-TEST and LCT-TR-IMC-11. Respondents must be authorized distributors of Data Innovations LLC, the software vendor, and must provide a formal letter of authorization along with their business size status, CAGE code, and Unique Entity ID. The notice explicitly states it is not a solicitation, nor does it obligate the government to issue a contract or award funding; responses are voluntary, unpaid, and will not be evaluated or acknowledged. Any future procurement, if initiated, will be announced through the Government-Wide Point of Entry, and potential offerors are responsible for monitoring SAM.gov for updates. The place of performance is specified as Joint Base Lewis-McChord, WA, and submissions must be sent via email to designated points of contact by the deadline of July 29, 2026, in Word, PDF, or plain text format, with a mandated subject line. The NAICS code is 541519, with a small business size standard of $34 million in annual revenue, though no socioeconomic set-asides are planned. No pricing, delivery schedules, contract clauses, inspection criteria, or evaluation factors are included, as this is purely a pre-solicitation market research tool to inform future acquisition decisions.
Defense Health Agency Hcd West

POSTED

about 6 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541519
New
Federal
DA01--Data Engineering, Management Support and Quality Assurance Recommendations (VA-26-00062403)
Solicitation # 36C10B26Q0632
The contract solicitation DA01–Data Engineering, Management Support and Quality Assurance Recommendations (VA-26-00062403), identified by solicitation number 36C10B26Q0632, is a Firm-Fixed-Price (FFP) procurement issued by the Department of Veterans Affairs, Technology Acquisition Center, with a small business set-aside reserved entirely for small businesses. The solicitation has been amended to extend the response deadline to Wednesday, August 12, 2026, at 3:00 PM EST, with no further questions permitted. Proposals must be submitted electronically to the designated contacts and organized into five mandatory volumes formatted according to strict specifications: Volume I (Technical Factor One: Case Studies) is limited to six pages in .doc or .docx format, excluding cover pages and artifacts, while Volumes II through V, covering Price, Past Performance, Veterans Involvement, and Certifications, must be submitted as .pdf files with no page limits. The offeror must self-certify as a small business and, if applicable, provide verification for Service-Disabled Veteran-Owned Small Business (SDVOSB) or Veteran-Owned Small Business (VOSB) status through the SBA VetCert database. Performance is evaluated under a best-value trade-off framework with Technical Factor One being the most critical, requiring at least an “Acceptable” rating to remain eligible; Price is slightly more important than Past Performance, which itself slightly outweighs Veterans Involvement, with all non-price factors collectively carrying greater weight than cost. The work scope includes end-to-end data engineering, system integration, project management, and quality assurance under a 12-month base period with two optional 12-month extensions, all governed by a Performance Work Statement requiring monthly deliverables such as project plans, progress reports, and data analysis briefings. Contractors must comply with rigorous federal and VA-specific standards, including FISMA, Section 508 accessibility (WCAG 2.0 AA), NIST SP 800-88 for data sanitization, FIPS 140-2 for encryption, and VA Directives 6500 and 710. Security requirements mandate that all personnel sign VA’s Information Security Rule of Behavior, complete VA Form 0752, and have access revoked within 24 hours of termination; the use of external media is prohibited and critical system vulnerabilities must be patched
Technology Acquisition Center Nj (36C10B)

POSTED

about 6 hours ago

DEADLINE

in 1 day
View Details
NAICS: 541519
New
Federal
High Frequency Radio Maintenance Support Services for the DOE/NNSA Office of Emergency Operations (NA-40)The National Nuclear Security Administration under the Department of Energy is seeking providers to deliver high frequency radio maintenance support services for its Office of Emergency Operations. This requirement is targeted at ensuring mission-critical communication systems remain operational and reliable, particularly in emergency response scenarios where robust and secure radio infrastructure is essential. The work will primarily be performed in the District of Columbia, and the contract is classified under NAICS code 541519 for other computer-related services, indicating a focus on technical support and system maintenance rather than hardware manufacturing or software development. The agency has identified this as a procurement opportunity with a public forecast posting date of August 10, 2026, suggesting it is in the early planning phase ahead of a formal solicitation. Point of contact for small business inquiries is Chelsea Murphy, the Small Business Program Manager, who can be reached via email for further details on eligibility, participation, or anticipated timeline. There is no current solicitation number or set-aside designation listed, but the contract is expected to prioritize service excellence, system uptime, and rapid response capabilities to sustain national security communications.
National Nuclear Security Administration

POSTED

about 20 hours ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services

Same awarding agency

NAICS: 513210
Federal
Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription
Solicitation # 7571TE26Q00153
The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.
Software Publishers

POSTED

7 days ago

DEADLINE

in 3 days
View Details
NAICS: 541715
Federal
Antioxidant Therapy for Smith-Lemli-Opitz Syndrone
Solicitation # NICHD-08610
The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

in 7 days
View Details
NAICS: 562111
Federal
Notice of Intent / Sole Source Solid Waste
Solicitation # 75H71026Q00223
The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.
Solid Waste Collection

POSTED

12 days ago

DEADLINE

in 7 days
View Details
NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 months ago

DEADLINE

in 8 months
View Details